Universidad Complutense de Madrid
E-Prints Complutense

Mesoporous core-shell silica nanoparticles with anti-fouling properties for ovarian cancer therapy

Impacto

Downloads

Downloads per month over past year



Sánchez Salcedo, Sandra and Vallet Regí, María and Allaf Shanin, Sophia and Glackin, Carlotta A. and Zinck, Jeffrey I. (2018) Mesoporous core-shell silica nanoparticles with anti-fouling properties for ovarian cancer therapy. Chemical Engineering Journal . ISSN 1385-8947

[img] PDF
Restringido a Repository staff only hasta 8 January 2020.

3MB

Official URL: https://www.elsevier.com/




Abstract

Mesoporous silica nanoparticles (MSNPs) have many potential applications in biomedical fields. However, when MSNPs are exposed to plasma, protein adsorption leads to opsonization and decreases blood circulation time. A new multifunctional nanodevice based on polyethylenimine (PEI) coated core-shell Fe⁠3O⁠4@SiO⁠2 MSNPs with a zwitterionic 2-methacryloyloxyethyl phosphorylcholine (MPC) surface was designed to minimize unspecific protein adhesion. Particle size measurements demonstrated an excellent non-fouling capacity in solutions containing Bovine Serum Albumin (BSA) and Fetal Bovine Serum (FBS) plasma proteins. The system was used in this study to co-deliver two different cargos: siRNA and daunorubicin. Anti-TWIST siRNA plays critical role in modulating knockdown of TWIST and sensitizing cells to chemotherapeutics such as daunorubicin for ovarian cancer therapy. The drug was released in response to externally controlled oscillating magnetic fields (OMF).
siRNA (siGFP) silenced expression of green fluorescence protein (GFP) in Ovcar8 cancer cells, demonstrating the incorporation of core shell MSNPs into cells and siGFP delivery. The synergistic effect of the co-release of anti-TWIST-siRNA loaded in the PEI and daunorubicin loaded in NPs’ pores caused increased cytotoxicity in Ovcar8 of up to 50% from both zwitteronic and non-zwitteronic NPs. The system is the first example of silencing by anti-TWITS-siRNA/daunorubicin co-delivered using zwitterionic core-shell nanoparticles with low-fouling adsorption. This engineered multifunctional approach may provide therapeutic potential for the treatment of currently incurable ovarian cáncer.


Item Type:Article
Additional Information:

RESEARCHER ID N-4501-2014 (Sandra Sánchez Salcedo)
ORCID 0000-0002-1889-2057 (Sandra Sánchez Salcedo)
RESEARCHER ID M-3378-2014 (María Vallet Regí)
ORCID 0000-0002-6104-4889 (María Vallet Regí)

Uncontrolled Keywords:Zwitterion, PEI core-shell MSNPs, Co-delivery, siRNA, Daunorubicin, Cancer therapy
Subjects:Sciences > Chemistry > Materials
Sciences > Chemistry > Chemistry, Inorganic
ID Code:45938
Deposited On:05 Feb 2018 18:30
Last Modified:06 Feb 2018 11:50

Origin of downloads

Repository Staff Only: item control page